Drugs / Systane Balance
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01207752 | Sep 2010 → Jul 2011 | eye adnexa disorder | Southern California College of Optometry at Marshall B. Ketchum University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04111965 Comparator | Dec 2020 → Dec 2021 | dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Systane Balance | “Patients (phase I: n = 25 and phase II: n = 101) were assigned to receive either PRO-176 (Nanodrop®) or Systane Balance® (control)” PMID 37077305 ↗ Apr 2023 |
| Route | Topical | “Artificial tear emulsion drop” NCT01207752 ↗ |